These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease. Buchanan RR; Wardlaw JR; Riglar AG; Littlejohn GO; Miller MH J Rheumatol; 1989 Jun; 16(6):757-61. PubMed ID: 2778757 [TBL] [Abstract][Full Text] [Related]
5. Increased EA-rosette formation by lymphocytes from patients with rheumatoid arthritis. Sharpin RK; Wilson JD Clin Exp Immunol; 1977 Aug; 29(2):205-12. PubMed ID: 908172 [TBL] [Abstract][Full Text] [Related]
6. The quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Lin SC; Chen KH; Lin CH; Kuo CC; Ling QD; Chan CH Eur J Clin Invest; 2007 Dec; 37(12):987-96. PubMed ID: 18036033 [TBL] [Abstract][Full Text] [Related]
7. Levels of IgD in patients with rheumatoid arthritis. Kholmogorova GT; Stefani DV Allergol Immunopathol (Madr); 1982; 10(3):211-4. PubMed ID: 6816052 [TBL] [Abstract][Full Text] [Related]
8. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to native type I collagen in childhood rheumatic diseases. Rosenberg AM; Hunt DW; Petty RE J Rheumatol; 1984 Aug; 11(4):421-4. PubMed ID: 6332906 [TBL] [Abstract][Full Text] [Related]
10. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954 [TBL] [Abstract][Full Text] [Related]
11. Phagocytosis, bactericidal capacity, and PGE2 production of monocytes in systemic lupus erythematosus and rheumatoid arthritis. Cruchaud A; Despont JP; Roth A; Dayer JM Diagn Immunol; 1984; 2(4):203-12. PubMed ID: 6597049 [TBL] [Abstract][Full Text] [Related]
12. IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. Cook AD; Mackay IR; Cicuttini FM; Rowley MJ J Rheumatol; 1997 Nov; 24(11):2090-6. PubMed ID: 9375865 [TBL] [Abstract][Full Text] [Related]
14. Monocyte function in rheumatoid arthritis. Bar-Eli M; Ehrenfeld M; Litvin Y; Gallily R Scand J Rheumatol; 1980; 9(1):17-23. PubMed ID: 6769149 [TBL] [Abstract][Full Text] [Related]
15. The use of T cell subtyping to distinguish rheumatoid arthritis from systemic lupus erythematosus. Traycoff RB; Rogers WW; Gregory SA J Rheumatol; 1981; 8(3):494-7. PubMed ID: 6974781 [TBL] [Abstract][Full Text] [Related]
17. Occurrence of deficient monocyte yeast cell phagocytosis in presence of rheumatic sera. Svensson B Scand J Rheumatol Suppl; 1980; 31():21-7. PubMed ID: 6992265 [TBL] [Abstract][Full Text] [Related]
18. Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Park YW; Kee SJ; Cho YN; Lee EH; Lee HY; Kim EM; Shin MH; Park JJ; Kim TJ; Lee SS; Yoo DH; Kang HS Arthritis Rheum; 2009 Jun; 60(6):1753-63. PubMed ID: 19479851 [TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159 [TBL] [Abstract][Full Text] [Related]
20. In vitro immunoglobulin synthesis by lymphocytes from patients with rheumatoid arthritis. I. Effect of monocyte depletion and demonstration of an increased proportion of lymphocytes forming rosettes with mouse erythrocytes. Plater-Zyberk C; Clarke MF; Lam K; Mumford PA; Room GR; Maini RN Clin Exp Immunol; 1983 Jun; 52(3):505-11. PubMed ID: 6603295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]